SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1
Search This Board: 
Last Post: 10/21/2017 5:35:11 PM - Followers: 217 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
SureTrader
Interactive Brokers Advertisement
NVAX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX News: Current Report Filing (8-k) 10/13/2017 05:17:03 PM
NVAX News: Novavax Announces Leadership Change 10/13/2017 07:30:37 AM
NVAX News: Novavax Announces Leadership Change 10/13/2017 07:30:00 AM
NVAX News: Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference 09/19/2017 04:05:28 PM
NVAX News: Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference 09/19/2017 04:05:00 PM
PostSubject
#4870   sorry, wrong board tiv111 10/21/17 05:35:11 PM
#4869   Hate to say it but this was Glickman's tiv111 10/20/17 05:31:16 PM
#4868   Agree. Bought some myself at what I I Need Money 10/20/17 09:21:00 AM
#4867   Nice recovery yesterday on heavy volume. Anybody the gipper 10/20/17 07:11:32 AM
#4866   Ummm, no, it's not. I Need Money 10/19/17 07:21:46 PM
#4865   Got myself some shares around a buck. I Need Money 10/19/17 07:20:44 PM
#4864   Let’s hope it’s good news Dgoff 10/19/17 06:08:52 PM
#4863   Volume precedes price, news coming bleu22 10/19/17 03:45:25 PM
#4862   Thank you for some more cheapies bleu22 10/19/17 10:49:53 AM
#4861   CFO RESIGNING!!!DIRECTOR SELLING OVER 175,000 SHARES!!!! STOCK IS RMD1 10/18/17 10:05:45 AM
#4860   There's something truly satisfying about investor panic, lol. Syzygenic 10/17/17 04:05:05 PM
#4859   Diving deep Dgoff 10/17/17 03:29:05 PM
#4858   Stan needs to put some good news out. Soon bleu22 10/16/17 01:18:39 PM
#4857   Seems prices dropped slightly from news of “Buck” leaving. Dgoff 10/16/17 11:57:18 AM
#4856   Are there any upcoming dates for news specifically gastric 10/13/17 03:54:31 PM
#4855   Lmao Right Dgoff 10/13/17 03:47:56 PM
#4854   Means BUY BUY BUY tabuhasna 10/13/17 09:02:36 AM
#4853   “Buck” is resigning. What now? Dgoff 10/13/17 07:51:35 AM
#4852   Shorts r covering, news is coming bleu22 10/11/17 03:55:07 PM
#4851   Going in for 5k at 1.18 lets see don estaban 10/11/17 01:50:22 PM
#4850   I jumped in on the basing setup. I Syzygenic 10/11/17 01:31:16 PM
#4849   I agree...another little fake pop with this 1:00PM Gup80 10/11/17 01:20:00 PM
#4848   Heavy accumulation Grandmasters 10/11/17 11:15:32 AM
#4847   Nice HOD close bleu22 10/10/17 04:13:13 PM
#4846   In stable position Grandmasters 10/10/17 11:15:37 AM
#4845   Is this stock every going to pop. Dgoff 10/10/17 06:28:42 AM
#4844   I'm in. Syzygenic 10/06/17 12:00:44 PM
#4843   She's turning the corner. Seaport Global initiated Novavax Saskey 10/06/17 11:28:58 AM
#4842   Wise grey say, don’t get greedy. I’m holding Saskey 10/04/17 05:57:05 PM
#4841   Its way too early for those temps to Scotttrader80 10/02/17 05:32:44 PM
#4840   The hour is nigh upon us. 40 degrees Saskey 10/02/17 05:27:55 PM
#4839   Theres a chill in the nights air cause Scotttrader80 09/29/17 08:31:06 PM
#4838   The snot is coming, trust me. Diwali. Halloween. Saskey 09/29/17 05:38:42 PM
#4837   NVAX Conference key takeaways RSV VACCINE -Novavax is the leader imapro 09/26/17 11:32:36 AM
#4836   Data on over 1500 patients that verify the bleu22 09/26/17 11:25:51 AM
#4835   We just started. Can anyone provide updates? At Ross92 09/26/17 11:00:37 AM
#4834   Novavax to Present at the Ladenburg Thalmann 2017 imapro 09/26/17 10:31:49 AM
#4833   Yes a tug of war happening !!! don estaban 09/25/17 04:10:04 PM
#4832   Looks like bulls and bears fighting it out. bleu22 09/25/17 04:02:22 PM
#4830   NVAX on fire today! Conference tomorrow! https://finance.yahoo.com/news/novav imapro 09/25/17 01:29:41 PM
#4829   I'm in! Been watching for bids to go makingbiigdough 09/25/17 10:44:43 AM
#4828   5.5 million shares first hour or so don estaban 09/25/17 10:44:38 AM
#4827   Great been waiting for a bit so lets don estaban 09/25/17 10:36:32 AM
#4826   Bid building bleu22 09/25/17 10:35:55 AM
#4825   Hopefully a little bit of both. Big news bleu22 09/25/17 10:25:30 AM
#4824   Shorts covering or news coming ? don estaban 09/25/17 10:15:57 AM
#4823   Alot of buying at ask today, usually between don estaban 09/21/17 11:32:50 AM
#4822   Where we going? Seems to have trouble moving up don estaban 09/19/17 05:40:15 PM
#4821   The bottom line is that, at least in bleu22 09/19/17 05:09:34 PM
#4820   NVAX NEWS OUT TRIALS BEGINNING https://finance.yahoo.com/news/novavax-initiates imapro 09/19/17 12:57:04 PM
PostSubject